JAZZ
Jazz Pharmaceuticals PLC
234.90$
-2.4%
vs. previous close
Closing price · As of: Sep 23, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +4.1% | -10.9% | +13.5% | +3.0% | +3.1% | -17.5% | +16.5% | +7.7% | +6.4% | -10.8% | +13.0% | – | |
| – | +153.3% | -63.1% | +15.1% | +1.6% | +15.3% | -18.7% | +11.1% | +121.7% | -90.4% | +1,143.1% | -62.0% | – | |
| – | -13.4% | +7.1% | +13.3% | +3.2% | +1.7% | -17.3% | +17.2% | -6.6% | +35.1% | -35.0% | +43.2% | – | |
| – | -7.6% | +2.9% | -0.9% | -9.4% | +20.3% | -24.9% | +5.2% | +26.7% | -28.8% | -21.8% | +54.7% | – | |
| – | +28.5% | -11.2% | -3.7% | -3.8% | +13.4% | +39.2% | -30.3% | +48.1% | -23.4% | -13.2% | +10.3% | – | |
| – | -21.0% | +34.4% | -3.5% | -4.4% | +12.5% | +10.5% | +90.3% | -49.8% | -67.4% | +107.8% | +53.8% | – | |
| – | +17.3% | -67.3% | +201.2% | +30.5% | -26.7% | -129.3% | – | – | +1,481.0% | -76.5% | +16.1% | – | |
| – | +25.4% | -26.3% | -6.2% | -5.4% | -12.7% | +4.8% | -11.8% | +2.6% | -6.5% | +39.4% | -41.4% | – | |
| – | -38.3% | -104.8% | – | +45.4% | -33.6% | -182.8% | – | – | +2,205.3% | +43.7% | -29.5% | – | |
| – | – | – | -362.7% | – | – | – | – | – | – | +25.1% | +196.7% | – | |
| – | -35.9% | -115.5% | – | +27.6% | -11.1% | -148.4% | – | – | -19.1% | +44.1% | -34.2% | – | |
| – | +8.3% | -25.7% | +35.2% | +16.9% | -6.5% | -65.0% | -470.3% | – | +18.1% | +95.3% | -23.1% | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.